Evidence map›Paper›PMID 25114257›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2014

Receptor usage and cell entry of bat coronavirus HKU4 provide insight into bat-to-human transmission of MERS coronavirus.

Yang Yang, Lanying Du, Chang Liu, Lili Wang, Cuiqing Ma, Jian Tang, Ralph S Baric, Shibo Jiang, Fang Li

Abstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 211 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
211citing papers in PubMed, 1 pooled it
13.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

211 citing papers in PubMed, 1 synthesis or guideline pooled it, 296 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Journal of virology · 2025
    Article
  19. Article
  20. Article

151 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 2 countries.

Yang YangDepartment of Pharmacology, University of Minnesota Medical School, Minneapolis, MN 55455;
Lanying DuLindsley F. Kimball Research Institute, New York Blood Center, New York, NY 10065;
Chang LiuDepartment of Pharmacology, University of Minnesota Medical School, Minneapolis, MN 55455;
Lili WangLindsley F. Kimball Research Institute, New York Blood Center, New York, NY 10065;
Cuiqing MaLindsley F. Kimball Research Institute, New York Blood Center, New York, NY 10065;
Jian TangLindsley F. Kimball Research Institute, New York Blood Center, New York, NY 10065;
Ralph S BaricDepartment of Epidemiology, University of North Carolina, Chapel Hill, NC 27559; and.
Shibo JiangLindsley F. Kimball Research Institute, New York Blood Center, New York, NY 10065; Key Laboratory of Medical Molecular Virology of Ministries of Education and Health, Shanghai Medical College and Institute of Medical Microbiology, Fudan University, Shanghai 200032, China lifang@umn.edu sjiang@nybloodcenter.org.
Fang LiDepartment of Pharmacology, University of Minnesota Medical School, Minneapolis, MN 55455; lifang@umn.edu sjiang@nybloodcenter.org.
New York Blood Center · USUniversity of Minnesota Medical Center · USShanghai Medical College of Fudan University · CNUniversity of Minnesota · USUniversity of North Carolina at Chapel Hill · US

Funding

Receptor recognition mechanisms of coronavirusesR01AI089728 · NIAID · UNIVERSITY OF MINNESOTA · PI Fang Li, Timothy Patrick Sheahan · 2010 to 2026
$4.7M
Critical neutralizing domain-based vaccines against new SARS-like virus hCoV-EMCR21AI109094 · NIAID · NEW YORK BLOOD CENTER · PI DU, LANYING · 2014 to 2015
$466k
NIAID NIH HHS R01 AI089728NIAID NIH HHS R01AI089728NIAID NIH HHS R21 AI109094NIAID NIH HHS R21AI109094
6 · The paper itself

Abstract

Middle East respiratory syndrome coronavirus (MERS-CoV) currently spreads in humans and causes ∼ 36% fatality in infected patients. Believed to have originated from bats, MERS-CoV is genetically related to bat coronaviruses HKU4 and HKU5. To understand how bat coronaviruses transmit to humans, we investigated the receptor usage and cell entry activity of the virus-surface spike proteins of HKU4 and HKU5. We found that dipeptidyl peptidase 4 (DPP4), the receptor for MERS-CoV, is also the receptor for HKU4, but not HKU5. Despite sharing a common receptor, MERS-CoV and HKU4 spikes demonstrated functional differences. First, whereas MERS-CoV prefers human DPP4 over bat DPP4 as its receptor, HKU4 shows the opposite trend. Second, in the absence of exogenous proteases, both MERS-CoV and HKU4 spikes mediate pseudovirus entry into bat cells, whereas only MERS-CoV spike, but not HKU4 spike, mediates pseudovirus entry into human cells. Thus, MERS-CoV, but not HKU4, has adapted to use human DPP4 and human cellular proteases for efficient human cell entry, contributing to the enhanced pathogenesis of MERS-CoV in humans. These results establish DPP4 as a functional receptor for HKU4 and host cellular proteases as a host range determinant for HKU4. They also suggest that DPP4-recognizing bat coronaviruses threaten human health because of their spikes' capability to adapt to human cells for cross-species transmissions.

Indexed as

AnimalsChiropteraCoronavirusCoronavirus InfectionsDipeptidyl Peptidase 4Disease ReservoirsHost-Pathogen InteractionsHost SpecificityHumansMiddle EastReceptors, VirusRespiratory Tract InfectionsSpike Glycoprotein, CoronavirusVirulenceVirus InternalizationDipeptidyl Peptidase 4DPP4 protein, humanReceptors, VirusSpike Glycoprotein, Coronavirus

Identifiers

PMID25114257
PMCPMC4151778
OpenAlexW2146242600

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.